Asia Pacific Multiplex Assay Market Forecast 2019-2027

KEY FINDINGS

The Asia Pacific market for the multiplex assay is predicted to exhibit a CAGR of 10.28% during the projected period of 2019-2027. The market growth in the overpopulated region is driven by the increasing research and development activities, growing demand for healthcare facilities, rise in healthcare reforms, and technological advancements.

MARKET INSIGHTS

The market of the multiplex assay in the Asian Pacific region is separated into regions of South Korea, Australia, China, Japan, India, and the rest of Asia Pacific for further analysis. There is a steady growth in the South Korean market due to an increase in the demand for quality healthcare, demand for molecular testing and point-of-care testing , and efforts by the government to increase the use of these products by promoting medical tourism, implementing u-healthcare and regulating multiplex assay. In Australia, the emerging use of the multiplex assay in IVD is garnering attention. The treatments which allow multiplex assay are cost effective as they are specific. They are critical in the use of cancer drugs in Australia. The rest of Asia Pacific includes countries such as Indonesia, South Korea, Philippines, Malaysia, Thailand, Singapore, Vietnam, and others. The market in these regions are mainly propelled by the growing focus of the government in research and development of precision medicine for liver cancer.

COMPETITIVE INSIGHTS

Merck Millipore, Meso Scale Diagnostics LLC, Olink Proteomics AB, Qiagen, Randox Laboratories Ltd, Randox Laboratories Ltd, Siemens Healthineers, Thermo Fisher, etc. are some of the key players in the market.

Our report offerings include:

• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Table of contents

1. RESEARCH SCOPE

• 1.1. STUDY GOALS
• 1.2. SCOPE OF THE MARKET STUDY
• 1.3. WHO WILL FIND THIS REPORT USEFUL?
• 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

• 2.1. SOURCES OF DATA
• 2.1.1. SECONDARY DATA
• 2.1.2. PRIMARY DATA
• 2.2. TOP-DOWN APPROACH
• 2.3. BOTTOM-UP APPROACH
• 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

• 3.1. MARKET SUMMARY
• 3.2. KEY FINDINGS
• 3.2.1. NUCLEIC ACID-BASED MULTIPLEX ASSAYS ARE THE FASTEST GROWING TYPE
• 3.2.2. REAGENTS AND CONSUMABLES ARE THE WIDELY USED PRODUCTS
• 3.2.3. MULTIPLEX PCR IS THE VASTLY DEMANDING MULTIPLEX ASSAY TECHNOLOGY
• 3.2.4. MULTIPLEX ASSAYS ARE HIGHLY ECONOMICAL ASSAY

4. MARKET DYNAMICS

• 4.1. MARKET SCOPE & DEFINITION
• 4.2. MARKET DRIVERS
• 4.2.1. GROWING R&D ACTIVITIES & GOVERNMENTAL FUNDING
• 4.2.2. PREFERENCE OF MULTIPLEX ASSAYS OVER CONVENTIONAL ASSAYS
• 4.2.3. INCREASED IN THE ADOPTION OF PERSONALIZED MEDICINES
• 4.3. MARKET RESTRAINTS
• 4.3.1. LACK OF SKILLED PROFESSIONALS
• 4.4. MARKET OPPORTUNITIES
• 4.4.1. GROWING OPPORTUNITIES IN THE EMERGING ECONOMIES
• 4.4.2. IDENTIFICATION OF NOVEL BIOMARKERS
• 4.5. MARKET CHALLENGES
• 4.5.1. STRINGENT REGULATIONS

5. MARKET BY TYPE

• 5.1. PROTEIN-BASED MULTIPLEX ASSAYS
• 5.2. NUCLEIC ACID-BASED MULTIPLEX ASSAYS
• 5.3. OTHER MULTIPLEX ASSAYS

6. MARKET BY PRODUCT

• 6.1. REAGENTS AND CONSUMABLES
• 6.2. INSTRUMENTS AND ACCESSORIES
• 6.3. SOFTWARE AND SERVICES

7. MARKET BY TECHNOLOGY

• 7.1. MULTIPLEX PROTEIN MICROARRAY
• 7.2. MULTIPLEX PCR
• 7.3. OTHER TECHNOLOGY

8. MARKET BY APPLICATION

• 8.1. CLINICAL DIAGNOSTICS
• 8.2. RESEARCH AND DEVELOPMENT
• 8.3. COMPANION DIAGNOSTICS

9. MARKET BY END-USER

• 9.1. HOSPITALS
• 9.2. CLINICAL LABORATORIES
• 9.3. RESEARCH INSTITUTES
• 9.4. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

10. KEY ANALYTICS

• 10.1. PORTER'S FIVE FORCES MODEL
• 10.1.1. THREAT OF NEW ENTRANTS
• 10.1.2. THREAT OF SUBSTITUTE PRODUCTS
• 10.1.3. BARGAINING POWER OF BUYER
• 10.1.4. BARGAINING POWER OF SUPPLIER
• 10.1.5. INTENSITY OF COMPETITIVE RIVALRY
• 10.2. KEY BUYING CRITERIA
• 10.3. KEY TRENDS
• 10.4. OPPORTUNITY MATRIX

11. GEOGRAPHICAL ANALYSIS

• 11.1. ASIA PACIFIC
• 11.1.1. JAPAN
• 11.1.2. CHINA
• 11.1.3. INDIA
• 11.1.4. SOUTH KOREA
• 11.1.5. AUSTRALIA
• 11.1.6. REST OF ASIA-PACIFIC

12. COMPETITIVE LANDSCAPE

• 12.1. MARKET SHARE ANALYSIS
• 12.2. COMPANY PROFILES
• 12.2.1. ABCAM PLC.
• 12.2.2. AGILENT TECHNOLOGIES, INC.
• 12.2.3. BECTON DICKINSON AND COMPANY
• 12.2.4. BIO-RAD LABORATORIES, INC.
• 12.2.5. BIO-TECHNE CORPORATION
• 12.2.6. ILLUMINA, INC
• 12.2.7. LUMINEX CORPORATION
• 12.2.8. MERCK MILIPORE
• 12.2.9. MESO SCALE DIAGNOSTICS, LLC
• 12.2.10. OLINK PROTEOMICS AB
• 12.2.11. QIAGEN N.V.
• 12.2.12. RANDOX LABORATORIES LTD.
• 12.2.13. SEEGENE INC.
• 12.2.14. SIEMENS HEALTHINEERS
• 12.2.15. THERMO FISHER SCIENTIFIC INC.

LIST OF TABLES

• TABLE 1: ASIA PACIFIC MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
• TABLE 2: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)
• TABLE 3: ASIA PACIFIC PROTEIN-BASED MULTIPLEX ASSAYS MARKET, 2019-2027 ($ MILLION)
• TABLE 4: ASIA PACIFIC NUCLEIC ACID-BASED MULTIPLEX ASSAYS MARKET, 2019-2027 ($ MILLION)
• TABLE 5: ASIA PACIFIC OTHER MULTIPLEX ASSAYS MARKET, 2019-2027 ($ MILLION)
• TABLE 6: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)
• TABLE 7: ASIA PACIFIC REAGENTS AND CONSUMABLES MARKET, 2019-2027 ($ MILLION)
• TABLE 8: ASIA PACIFIC INSTRUMENTS AND ACCESSORIES MARKET, 2019-2027 ($ MILLION)
• TABLE 9: ASIA PACIFIC SOFTWARE AND SERVICES MARKET, 2019-2027 ($ MILLION)
• TABLE 10: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
• TABLE 11: ASIA PACIFIC MULTIPLEX PROTEIN MICROARRAY MARKET, 2019-2027 ($ MILLION)
• TABLE 12: ASIA PACIFIC MULTIPLEX PCR MARKET, 2019-2027 ($ MILLION)
• TABLE 13: ASIA PACIFIC OTHER TECHNOLOGY MARKET, 2019-2027 ($ MILLION)
• TABLE 14: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
• TABLE 15: ASIA PACIFIC CLINICAL DIAGNOSTICS MARKET, 2019-2027 ($ MILLION)
• TABLE 16: ASIA PACIFIC RESEARCH AND DEVELOPMENT MARKET, 2019-2027 ($ MILLION)
• TABLE 17: ASIA PACIFIC COMPANION DIAGNOSTICS MARKET, 2019-2027 ($ MILLION)
• TABLE 18: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)
• TABLE 19: ASIA PACIFIC HOSPITALS MARKET, 2019-2027 ($ MILLION)
• TABLE 20: ASIA PACIFIC CLINICAL LABORATORIES MARKET, 2019-2027 ($ MILLION)
• TABLE 21: ASIA PACIFIC RESEARCH INSTITUTES MARKET, 2019-2027 ($ MILLION)
• TABLE 22: ASIA PACIFIC PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, 2019-2027 ($ MILLION)
• TABLE 23: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY COUNTRY, 2019-2027 ($ MILLION)
• TABLE 24: JAPAN MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)
• TABLE 25: JAPAN MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)
• TABLE 26: JAPAN MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
• TABLE 27: JAPAN MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
• TABLE 28: JAPAN MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)
• TABLE 29: CHINA MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)
• TABLE 30: CHINA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)
• TABLE 31: CHINA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
• TABLE 32: CHINA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
• TABLE 33: CHINA MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)
• TABLE 34: INDIA MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)
• TABLE 35: INDIA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)
• TABLE 36: INDIA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
• TABLE 37: INDIA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
• TABLE 38: INDIA MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)
• TABLE 39: SOUTH KOREA MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)
• TABLE 40: SOUTH KOREA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)
• TABLE 41: SOUTH KOREA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
• TABLE 42: SOUTH KOREA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
• TABLE 43: SOUTH KOREA MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)
• TABLE 44: AUSTRALIA MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)
• TABLE 45: AUSTRALIA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)
• TABLE 46: AUSTRALIA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
• TABLE 47: AUSTRALIA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
• TABLE 48: AUSTRALIA MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)

LIST OF FIGURES

• FIGURE 1: ASIA PACIFIC MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
• FIGURE 2: ASIA PACIFIC MULTIPLEX ASSAY MARKET SHARE, BY TYPE, 2018 & 2027 (%)
• FIGURE 3: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY PROTEIN-BASED MULTIPLEX ASSAYS, 2019-2027 ($ MILLION)
• FIGURE 4: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY NUCLEIC ACID-BASED MULTIPLEX ASSAYS, 2019-2027 ($ MILLION)
• FIGURE 5: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY OTHER MULTIPLEX ASSAYS, 2019-2027 ($ MILLION)
• FIGURE 6: ASIA PACIFIC MULTIPLEX ASSAY MARKET SHARE, BY PRODUCT, 2018 & 2027 (%)
• FIGURE 7: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY REAGENTS AND CONSUMABLES, 2019-2027 ($ MILLION)
• FIGURE 8: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY INSTRUMENTS AND ACCESSORIES, 2019-2027 ($ MILLION)
• FIGURE 9: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY SOFTWARE AND SERVICES, 2019-2027 ($ MILLION)
• FIGURE 10: ASIA PACIFIC MULTIPLEX ASSAY MARKET SHARE, BY TECHNOLOGY, 2018 & 2027 (%)
• FIGURE 11: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY MULTIPLEX PROTEIN MICROARRAY, 2019-2027 ($ MILLION)
• FIGURE 12: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY MULTIPLEX PCR, 2019-2027 ($ MILLION)
• FIGURE 13: ADVANTAGES OF IMMUNOHISTOCHEMISTRY (IHC)
• FIGURE 14: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY OTHER TECHNOLOGY, 2019-2027 ($ MILLION)
• FIGURE 15: ASIA PACIFIC MULTIPLEX ASSAY MARKET SHARE, BY APPLICATION, 2018 & 2027 (%)
• FIGURE 16: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY CLINICAL DIAGNOSTICS, 2019-2027 ($ MILLION)
• FIGURE 17: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY RESEARCH AND DEVELOPMENT, 2019-2027 ($ MILLION)
• FIGURE 18: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY COMPANION DIAGNOSTICS, 2019-2027 ($ MILLION)
• FIGURE 19: ASIA PACIFIC MULTIPLEX ASSAY MARKET SHARE, BY END-USER, 2018 & 2027 (%)
• FIGURE 20: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY HOSPITALS, 2019-2027 ($ MILLION)
• FIGURE 21: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY CLINICAL LABORATORIES, 2019-2027 ($ MILLION)
• FIGURE 22: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY RESEARCH INSTITUTES, 2019-2027 ($ MILLION)
• FIGURE 23: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2019-2027 ($ MILLION)
• FIGURE 24: PORTER'S FIVE FORCE MODEL
• FIGURE 25: KEY BUYING CRITERIA
• FIGURE 26: NEWLY REGISTERED CLINICAL TRIAL STUDY 2016-2018
• FIGURE 27: JAPAN MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
• FIGURE 28: CHINA MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
• FIGURE 29: INDIA MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
• FIGURE 30: SOUTH KOREA MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
• FIGURE 31: AUSTRALIA MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
• FIGURE 32: REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
• FIGURE 33: MULTIPLEX ASSAY COMPANY MARKET SHARE ANALYSIS, 2018 (%)